Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cefixime + cloxacillin is a combination antibiotic medication used to treat various bacterial infections. This combination brings together two different types of antibiotics: cefixime, which is a third-generation cephalosporin, and cloxacillin, which is a penicillin-type antibiotic.
This combination works through a dual mechanism. Both antibiotics prevent the formation of bacterial cell walls, which are essential for bacterial survival in the human body. By targeting different aspects of cell wall synthesis, they provide a synergistic effect against various bacteria, particularly showing enhanced activity against Streptococcus pneumoniae and Haemophilus influenzae, common causes of community-acquired pneumonia.
Cefixime + cloxacillin is primarily used to treat:
The combination is effective against both gram-positive and gram-negative bacteria, providing broad-spectrum coverage.
The medication is available in various forms including tablets, capsules, and oral suspensions. The dosage depends on the severity of infection, patient age, and other factors. It's typically taken with food to reduce gastrointestinal side effects.
Common side effects include:
The combination is contraindicated in:
It should be used with caution in:
Cefixime + cloxacillin may interact with:
This combination is sometimes formulated with probiotics like Lactobacillus to help maintain gut flora balance that may be disrupted by antibiotic use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cefixime + Cloxacillin.